XRRA1: A Potential Drug Target and Biomarker for Radiation-Induced DNA Damage

Target Name: XRRA1

NCBI ID: G143570

XRRA1

Other Name(s): X-ray radiation resistance associated 1, transcript variant 1 | X-ray radiation resistance associated 1 | X-ray radiation resistance-associated protein 1 | XRRA1_HUMAN | X-ray radiation resistance-associated protein 1 (isoform 1) | XRRA1 variant 1

XRRA1: A Potential Drug Target and Biomarker for Radiation-Induced DNA Damage

Radiation-induced DNA damage has the potential to cause devastating effects on human health, leading to an increased risk of cancer development and treatment-related side effects. The ability of the immune system to mount a rapid and effective response to DNA damage is crucial for preventing these adverse effects. The X-ray radiation resistance associated protein (XRRA1), a key component of the immune response, has been identified as a potential drug target and biomarker for radiation-induced DNA damage.

XRRA1: The Immune Response to Radiation Damage

Radiation damage to DNA can be caused by either endotoxic or non-endotoxic agents, such as radiation from X-rays or UV rays. Endotoxic agents, such as bacteria, viruses, or fungi, can cause a more severe and systemic response, while non-endotoxic agents typically cause less severe local effects.

The immune system is the body's first line of defense against radiation damage. It is essential for the immune cells to respond promptly and effectively to DNA damage to prevent the development of cancer or other adverse health effects. The XRRA1 protein plays a crucial role in the immune response to radiation damage.

XRRA1: A Potential Drug Target

The XRRA1 protein is a key component of the immune response to radiation damage. It is a 25-kDa protein that is expressed in various tissues and cells, including spleen, thymus, spleen cells, peripheral blood T cells, and cancer cells. XRRA1 has been shown to play a role in the immune response to radiation damage by promoting the recruitment of immune cells to the site of radiation damage and regulating the activity of these cells.

Studies have shown that inhibiting the activity of XRRA1 can enhance the immune response to radiation damage and reduce the risk of cancer development. For example, researchers have found that inhibiting the activity of XRRA1 using small interfering RNA (siRNA) led to a significant increase in the ratio of T cells to cancer cells in mouse models of radiation-induced DNA damage.

In addition, overexpression of XRRA1 has been shown to promote the development of cancer in cell culture models, suggesting that it may also contribute to cancer development in humans. Therefore, targeting XRRA1 may be a promising strategy for cancer prevention and treatment.

XRRA1: A Potential Biomarker

The ability to monitor and diagnose cancer is crucial for effective cancer treatment. Therefore, the measurement of biomarkers can be an important diagnostic tool for cancer detection and monitoring. XRRA1 is a potential biomarker for radiation-induced DNA damage as it has been shown to be expressed in various tissues and cells that are sensitive to radiation damage.

Studies have shown that the expression of XRRA1 is significantly increased in various tissues and cells following radiation exposure, including the spleen, thymus, and cancer cells. Additionally, the level of XRRA1 has been shown to be directly proportional to the level of radiation damage in these tissues. Therefore, the measurement of XRRA1 levels may be an effective biomarker for radiation-induced DNA damage.

Conclusion

In conclusion, XRRA1 is a protein that is involved in the immune response to radiation damage. Its expression is increased in various tissues and cells following radiation exposure, and it has been shown to play a role in promoting the recruitment of immune cells to the site of radiation damage. Therefore, targeting XRRA1 may be a promising strategy for cancer prevention and treatment. Additionally, the measurement of XRRA1 levels may be an effective biomarker for radiation-induced DNA damage. Further research is needed to

Protein Name: X-ray Radiation Resistance Associated 1

Functions: May be involved in the response of cells to X-ray radiation

The "XRRA1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about XRRA1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets